Ginkgo Results Presentation Deck

Capital markets have been tough on growth biotech, but Ginkgo is in a stronger position than at any time in our history Daily Strain Tests Active Programs 49 5 11 14 13 6 2020 10,000,000 1,000,000 100,000 10,000 1,000 100 Diversified Business with Demonstrated Technical Success 10 Jan-151 Jan-16 71 5 Jan-17 18 21 17 10 2021 Government Jan-18 Pharma & Biotech Food & Agriculture Driving adoption of new technologies that yield step-change increases Industrial & Environmental Consumer & Technology Jan-19 Strain tests scaling 3x+ / year Jan-20 Jan-21 Jan-22 Multiple Recent Program Successes Ginkgo has more than doubled the number of products in scale production by our customers so far this year in diverse fields... Product Ginkgo organlar? Ginkgo proces Approx Year Started Year Completed Custona Primary End Market Organis Product Type Mig Scale H Downstream Sconomic Peach ✓ 2014 2019 Je ROBENTET Consumer Even 1500 Coconut [Confidential Royalty To ✓ 2010 2019 ROMAILT Consumer Boecies 3 ✓ Roy 2018 2018 (Content Chanical Rot Royal VCE Gregobam ✓ ✓ 2020 2021 Caldevron Pharma Myoglobin ✓ Ryany 2011 2021 Food Fungor Species G Equity CBG ✓ 2013 Launched first "Cell Development Kits" for protein production 2021 CRONOS Consumer Fungol Species cies 3 Species 4) Pict Sal Melecule Most being produced in tank at the 25,000-50,000 scale some pharme products produced at lower scals frundets to 1000L) NA Foo for service Small Molecule Confidential Miestone ✓ 2000 2021 Condema Pharma Bota Soacias CBGV ✓ ✓ 2010 2021 CRONOS Consumer Fal 500ps 5 Mestone Excerpt from Q3 2021 Earnings Deck O Integrated, Horizontal Platform Technology K 4x Y-O-Y Revenue Growth $77 $17 $59 2020 Strong Financial Health $314 $201 $113 2021 Biosecurity ($M) Foundry ($M) $1.5+ billion in cash yields runway ample 640+ World class team members Organizations served by 4,000+ Concentric, Ginkgo's biosecurity business (as of 3/20/2022) 313,000+ Square feet of lab space Property of Ginkgo Bioworks - 4 2021 UPDATE & BUSINESS REVIEW

View entire presentation